Decreased miR-181a expression in monocytes of obese patients is associated with the occurrence of metabolic syndrome and coronary artery disease.
about
Nutrigenetics and Nutrimiromics of the Circadian System: The Time for Human HealthMicroRNAs as potential signatures of environmental exposure or effect: a systematic reviewMicroRNA Regulatory Networks as Biomarkers in Obesity: The Emerging Role.The myriad essential roles of microRNAs in cardiovascular homeostasis and disease.MiR-181a regulates inflammation responses in monocytes and macrophagesThe continuum of personalized cardiovascular medicine: a position paper of the European Society of CardiologymiR-23 regulate the pathogenesis of patients with coronary artery diseasemiRNA profiles of monocyte-lineage cells are consistent with complicated roles in HIV-1 restriction.MicroRNA Regulation of Atherosclerosis.MicroRNA in cardiovascular calcification: focus on targets and extracellular vesicle delivery mechanisms.Stress in obesity and associated metabolic and cardiovascular disorders.miR-181a Induces Macrophage Polarized to M2 Phenotype and Promotes M2 Macrophage-mediated Tumor Cell Metastasis by Targeting KLF6 and C/EBPα.Role of miR-181 family in regulating vascular inflammation and immunityCirculating miRNAs: reflecting or affecting cardiovascular disease?miRNAs and long noncoding RNAs as biomarkers in human diseases.Reciprocal effects of Toll-like receptors and miRNAs on biological processes in human health and disease: a systematic review.Peripheral blood leucocyte subclasses as potential biomarkers of adipose tissue inflammation and obesity subphenotypes in humans.Characterization and predicted role of microRNA expression profiles associated with early childhood obesity.MicroRNAs, Regulatory Networks, and Comorbidities: Decoding Complex Systems.microRNA profiling in atherosclerosis, diabetes, and migraine.LPS induced miR-181a promotes pancreatic cancer cell migration via targeting PTEN and MAP2K4.Epigenetic regulation in monocyte/macrophage: A key player during atherosclerosis.microRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases.The impact of cryopreservation on human peripheral blood leucocyte bioenergetics.The miR-181d-regulated metalloproteinase Adamts1 enzymatically impairs adipogenesis via ECM remodeling.Maternal chromium restriction modulates miRNA profiles related to lipid metabolism disorder in mice offspring.Circulating microRNA-1a is a biomarker of Graves' disease patients with atrial fibrillation.MicroRNA profiling in migraine without aura: pilot study.MiR-23a Regulates the Vasculogenesis of Coronary Artery Disease by Targeting Epidermal Growth Factor Receptor.MiR-214 regulates the pathogenesis of patients with coronary artery disease by targeting VEGF.Over-expressed microRNA-181a reduces glomerular sclerosis and renal tubular epithelial injury in rats with chronic kidney disease via down-regulation of the TLR/NF-κB pathway by binding to CRY1
P2860
Q26765463-7B719C76-6874-4FF5-938B-1522DA5B76A7Q28393390-B41EFA49-E37A-4C80-88CD-D0C25841CDE6Q30402389-EB44B325-91DB-4BEF-8290-90A817DDD302Q34356918-41809186-B0D1-47DD-8623-DCEA317228B8Q34629860-644EEEBF-C358-4636-B11B-F42FA7EFD3EBQ34644992-B0F7DF16-AAC9-4241-A6E9-E08E027D9BF0Q36046963-C0D7008D-7568-4DC4-8725-77D50245CD31Q36395827-5400DBA8-3D43-460D-8F5B-F8177D81F7A9Q36602813-A8988703-2782-4FD0-9EE6-4DA63FFC7074Q36890424-4589F96F-7259-482E-B972-868B2C5D2BE2Q37288068-2AB6D3C4-FCD6-4E42-AE0E-24461F605F1BQ37325088-B1FA6F5C-A6BB-475C-83AA-F6AB20403529Q37619436-EDF0FD16-B6A8-42BE-8AF9-CBC91424F3BFQ38045189-70D39CB0-9BB2-486C-936C-B4FB76B4D503Q38088011-CFB1C267-06D7-4484-BE4A-ECB54701FAE1Q38148590-B2DD57D7-B607-402F-9BA9-06D275461759Q38164099-46E1B775-55BB-44CB-B83B-DD17DCA1D7F4Q38430435-00EE9982-61EA-4C30-B8D4-DEE644B2A0F3Q38821605-72F85A9C-D1F1-43F2-B9EA-506ED8DDF821Q38827929-AA9FDC2D-42C9-43E1-9B3F-72CF6BA2BD3BQ39023380-F44D647F-9DB1-4671-BCE5-6F45AD494C28Q39216733-4C901F09-A69D-4AD0-9FCC-82B2B86BFD57Q39403789-8D64019A-7DA7-4BF7-8E2A-459172242262Q42471619-CC875AA3-B101-4040-A63E-CDEC2D412491Q42709950-8A4C77CB-66A8-4491-BEE0-2E29413E4029Q47712492-1BF57A08-B321-4F6E-938E-0645F31EA950Q50621329-4AB7700F-3FB2-4326-9CCE-2BC1C327CFAEQ50989062-C4207910-7905-406B-A994-C745883B201BQ53120992-4F57AB90-613F-41FA-8B34-DBD21E557BFFQ53641313-28A1CA1A-7700-4AF2-8CE3-594DC1E4C00DQ58725690-C21A8B6C-86A5-4EE9-AB9E-F9C12C97B147
P2860
Decreased miR-181a expression in monocytes of obese patients is associated with the occurrence of metabolic syndrome and coronary artery disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Decreased miR-181a expression ...... e and coronary artery disease.
@en
Decreased miR-181a expression ...... e and coronary artery disease.
@nl
type
label
Decreased miR-181a expression ...... e and coronary artery disease.
@en
Decreased miR-181a expression ...... e and coronary artery disease.
@nl
prefLabel
Decreased miR-181a expression ...... e and coronary artery disease.
@en
Decreased miR-181a expression ...... e and coronary artery disease.
@nl
P2093
P921
P356
P1476
Decreased miR-181a expression ...... e and coronary artery disease.
@en
P2093
Bart Van der Schueren
Paul Holvoet
Peter Sinnaeve
Stefan Janssens
P304
P356
10.1210/JC.2012-1008
P407
P577
2012-04-24T00:00:00Z